Hospital-acquired Infections Market Research Report- Forecast to 2030

Hospital Acquired Infections Market Information, by Pathogen Types (Viral, Bacterial and Fungal), by Method of Treatment (Sterilization, Chemical, Radiation), Infection Type (Urinary Tract Infections, Blood Stream Infections, Surgical Site Infections, Gastrointestinal Infections, and Respiratory Infections) - Forecast till 2030

ID: MRFR/MED/1936-HCR | November 2022 | Region: Global | 84 Pages         

Hospital Acquired infections Market Speak to Analyst Request a Free Sample

Hospital-Acquired Infections Market Overview 


The Hospital-Acquired Infections Market was valued USD 23.7 billion and anticipated to achieve nearly USD 32.51 billion by 2030 at a CAGR of 1.37% during the forecast timeframe says Market Research Future (MRFR). In general, a hospital-acquired infection (HAI) is also known as the healthcare-associated infection (HAI or HCAI) or nosocomial infection. It is basically an infection type that is acquired in medical facilities. Usually, the patient gets admission for another disease to the hospital but gets the infection acquired in the medical facility. Hospital-Acquired Infections or symptoms usually occurs among the patients after getting discharged from the hospital. Also, it can be said that Hospital-Acquired Infections are more effective after the discharge of the patient. In addition, Hospital-Acquired Infections are also resulting in occupational infection among the hospital staff.


The Hospital-Acquired Infections has origins from another infected patient, outside environment, hospital staff who are infected in hospitals, or undetermined sources of the infections. According to the World Health Organisation (WHO), nearly over 1.4 million people across the world are getting affected by the 8.7% of hospital patients who had nosocomial infections.


However, the Hospital-Acquired Infections Market Analysis report highlights that the intended audiences are propelling the market growth in the forecast period. These intended audiences include hospital-acquired infections control drugs suppliers, HAI control drugs and instruments manufacturers, contract manufacturing organizations, private research laboratories, government research laboratories, market research and consulting service providers, and research and development (R&D) companies. 


COVID-19 Analysis 


The Hospital-Acquired Infections Market has experienced an overall market growth during the pandemic period of 2019 to 2020 as compared to the year 2018 to 2019. During the pandemic period, the increase in the adoption of infection-controlled products has been evident, which is projected to positively impact the global Market Value.


In addition, the global Market is anticipated to witness lucrative market growth in the future years. This is because the arrival of the covid-19 pandemic has proven to everyone how important it is to implement the control strategies to spread Hospital-Acquired Infections and infection prevention.


Market Dynamics 



  • Key Market Drivers 


The environmental factors such as bacterial load and infected materials in hospitals, temperature, crowding, humidity and many more are responsible for the growth of the Hospital-Acquired Infections Market. Also, the lack of awareness is fuelling the growth of the worldwide market. 


Moreover, the patient susceptibility such as immunity and other diseases; virulence and nature of the microbial agent; high prevalence of HAI; the age of the patient; bacterial resistance to drugs; poor hospital infrastructure and regulation; increasing chronic diseases with prolonged stay in medicals; low expenditure on healthcare; and others are some of the important factors for the increasing Hospital-Acquired Infections Market Size during the review period. 



  • Market Challenges 


The healthcare facility is one of the major challenges for the global Market in the research period. 


Moreover, sterilization technology requires more experts, which can be one of the bigger challenges for the worldwide market. 



  • Market Opportunities 


The global Hospital-Acquired Infections Market has significant opportunities for the vendors or market players due to the advancement in gas plasma sterilization technology. 


Moreover, the increasing research and development companies across the world are bringing lucrative opportunities for the global Market during the assessment period. 



  • Market Restraints 


The global Hospital-Acquired Infections Market Growthmight get affected because of the growth of microbial resistance counterfeit and spurious products. Moreover, the rise of disposables, off label use of drugs and antiseptics, great penetration of generics, huge fragmentation of the market along with the market players, and loss of patents are projected to hinder the global market growth during the forecast timeframe.


In addition, the rising use of quality construction materials like glass and ceramics in buildings is also one of the market restraints throughout the research period. 


Cumulative Evaluation Of The Market 


Significant market growth has been evident in the global market during the forecast timeframe. Further, it has been estimated that the advancement in the technology in the form of gas plasma sterilization technology is projected to drive the global Hospital-Acquired Infections in the further coming years. 


Moreover, the significant market players are contributing effectively to the market to enhance its performance in the upcoming years. 


Market Segmentation 


According to the Hospital-Acquired Infections Market Outlook report, the market has been segmented based on the methods of treatment, pathogen types, and infection type.



  • By methods of treatment:


Based on the methods of treatment, the Hospital-Acquired Infections Market has been categorized into chemical, protective barriers, sterilization, and radiation. 


Among these, the protective barriers segment is estimated to be one of the most important segments during the review timeframe.



  • By pathogen types:


In terms of the pathogen types segment, the worldwide Hospital-Acquired Infections Market has been classified into bacterial, viral, and fungal.



  • By infection type:


On the basis of infection type segment, the global Hospital-Acquired Infections Market has been segmented into bloodstream infections, gastrointestinal infections, urinary tract infections, surgical site infections, and respiratory infections.



  • By end-users:


Based on the end-user segment, the global Hospital-Acquired Infections Market has been segregated into ambulatory surgical centres, hospitals and clinics, and others.


In 2020, the hospitals and clinics segment was projected to hold the dominant position by generating the largest Market Share. This segment is expanding due to the growing number of hospitals and clinics, rise in prevalence of hospital-acquired infections, rise in geriatric population with increasing chronic diseases, and increasing demand for surgical procedures performed in hospitals. 


Regional Analysis 


Geographically, the worldwide Hospital-Acquired Infections Market has been classified based on different locations that include Asia Pacific, North America, Europe, South America, and the rest of the world. In the Mediterranean and Southeast Asia, the high prevalence of Hospital-Acquired Infections has been evident. The research report has also mentioned that there are some of the nations like Norway that have the least prevalence of Hospital-Acquired Infections because these nations are close to the extreme north of the Northern Hemisphere.


The American regions are considered to be the largest Hospital-Acquired Infections Market that has been anticipated to grow nearly $12 billion during the research period of 2022. The current market report explains that since 2016, the regional market for Hospital-Acquired Infections has experienced growth until the current year of 2022. Moreover, the European regional market for Hospital-Acquired Infections is candied to be the second-largest market during the forecast period. Furthermore, the Asia Pacific regional market is projected to be the fastest-growing place in the market for Hospital-Acquired Infections.


Competitive Outlook  


As per the Hospital-Acquired Infections Market Trends report, the presence of key players in different regions is contributing effectively to the worldwide market during the assessment period. These bigger market players include:



  • Advanced Sterilization Products, 

  • Becton Dickinson and company, 

  • Belimed AG,

  • 3M Company, 

  • Cantel Medical Corp.,

  • Getinge AB,

  • STERIS Corporation.


The Hospital-Acquired Infections Market Forecast report highlights that merger and acquisition is one of the great techniques adopted by the bigger market players to thrive the market growth throughout the review period. Also, these market players are focusing on the research and developing initiatives relating to Hospital-Acquired Infections, which is enhancing the global market growth. 


Recent Market Developments 



  • In October 2020, an automated touchscreen endoscope reprocessor named OER-Elite was launched by the prominent player Olympus. It is basically a part of the company's infection prevention product portfolio. This launch has enhanced the automated endoscope reprocessor (AER) lineup of the company that is helpful for the growth of the company. 

  • In February 2021, the biggest market player, Xenexhas, launched Deactivate. This device has aimed to disinfect surfaces in confined spaces as a handheld LED UV solution. 


Report Overview 


As per the global Hospital-Acquired Infections Market report, a detailed analysis of the market has been conducted by utilizing qualitative and quantitative analysis. This report has highlighted the market segments that are propelling the market growth. 


Moreover, this report has covered the market dynamics, market overview, regional analysis, competitive landscape analyses, and recent developments. It shows that the market has been contributed supportively by the key market players. 


Key Industrial Segments 


By methods of treatment



  • chemical, 

  • sterilization, 

  • protective barriers,

  • radiation


By pathogen types 



  • bacterial, 

  • viral, 

  • fungal


By infection type 



  • bloodstream infections, 

  • gastrointestinal infections, 

  • urinary tract infections, 

  • surgical site infections, 

  • respiratory infections


By end-users



  • ambulatory surgical centres, 

  • hospitals and clinics, 

  • others



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 32.51 billion
  CAGR    2030 1.37%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Pathogen Types, Method of Treatment, Infection Type
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Advanced Sterilization Products, 3M Company, Becton Dickinson and company, STERIS Corporation, Getinge AB, Cantel Medical Corp., Belimed AG
  Key Market Opportunities   Research and development (R&D) companies
  Key Market Drivers

  • Nature and virulence of the microbial agent, patient susceptibility
  • High prevalence of HAI
  • Technology advancement in the form of gas plasma sterilization technology


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The valuation of the global hospital-acquired infections market is expected to reach over USD 32.51 billion by the end of 2030

    The global hospital-acquired infections market is expected to register a CAGR over 1.37% during the assessment period (2020-2030).

    North America holds the largest share in the global hospital-acquired infections market followed by Europe and Asia Pacific, respectively.

    3M Company, Advanced Sterilization Products, Becton Dickinson and company, Getinge AB, STERIS Corporation, Cantel Medical Corp., and Belimed AG, are some of the major players operating in the global hospital-acquired infections market.